Skip to main content

Stomach Cancer Lawsuit Filed Against PPI Makers

Stomach Cancer Lawsuit Filed Against PPI Makers

Stomach Cancer Lawsuit Filed Against PPI Makers

Introduction

According to a lawsuit filed on October 11 in the U.S. District Court for the District of New Jersey, the use of Nexium, Prilosec, Nexium 24HR, and Prilosec OTC Prilosec caused him stomach cancer.

The plaintiff stated in the lawsuit that he took the heartburn medications in January 2013 and was diagnosed with stomach cancer in October 2015. This is one of the first lawsuits filed against the manufacturers of proton pump inhibitors (PPIs) over stomach cancer allegations. The lawsuit accuses the PPI manufacturers of negligent conduct and states, “despite their knowledge of the risks of stomach cancer associated with their proton pump inhibitors, Nexium, Nexium 24HR, Prilosec, and Prilosec OTC, defendants took no action to inform Plaintiff or Plaintiff’s physicians of this known risk.” Several individuals have filed lawsuits in the past blaming PPI drugs for their kidney problems. In December 2013, a study indicated the link between PPI drugs and gastric cancer and stated that the long-term use of the medication might double the risk.

This case is likely to be a part of the federal multidistrict (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation [No. II]), which currently comprises about 2,333 kidney injury lawsuits. Similar PPI lawsuits are centralized before Judge Claire C. Cecchi in the District of New Jersey for coordinated pretrial proceedings. Judge Cecchi has scheduled the first bellwether trial in the litigation for September 21, 2020.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!